8th Alfred P. Fishman Symposium

Pulmonary hypertension (PH) and pulmonary fibrosis/interstitial lung disease (ILD) are individually complex, progressive diseases with substantial morbidity and mortality. Pulmonary vascular dysfunction and parenchymal lung disease individually pose complex challenges to management. Increasingly, it is recognized that these diseases cannot be considered in isolation and frequently co-occur. The emergence of novel effective therapies in both diseases (including in combination) makes diagnosis, prognosis, treatment selection, and clinical trial design challenging.

The 2027 Alfred P. Fishman Symposium will address this rapidly evolving area. The proposed program brings together experts in ILD, pulmonary vascular disease, physiology, imaging, immunology, transplantation, and clinical trials to address an important unmet need: how to identify the biological and clinical phenotypes of patients with PF, PH, and PF-PH and translate that information into more appropriate treatment. The agenda specifically addresses ILD and PH diagnostics, evidence-based treatment, physiology, mechanisms of epithelial-endothelial and vascular-parenchymal crosstalk, clinical phenotyping, and challenging treatment decisions.

1. Apply diagnostic and treatment algorithms for ILD, PAH, and ILD-PH, incorporating current evidence-based and emerging therapies.
2. Explain the pathobiologic crosstalk between pulmonary endothelium and epithelium and its relevance in ILD and PH.
3. Formulate individualized treatment plans across ILD, CTD-PAH, ILD-PH, PAH, and sarcoid-PH phenotypes using a case-based approach.
4. Evaluate emerging clinical trial designs aimed at improving PH/ILD research.
5. Describe current regulatory perspectives on endpoints and regulatory pathways for PH and ILD, and discuss the ethical and methodological challenges of trial design in rare pulmonary disease.

REGISTRATION INFORMATION
Verified attendance includes access to view the presentations (videos and slides) online for one year. Pre-registration is required to attend. Walk-ins are discouraged. Please be sure to register in advance.

IN-PERSON REGISTRATION:
The fees to attend in-person are as follows: $250 for physicians, $350 for Industry attendees, $125 for nurse practitioners, physician assistants and other healthcare professionals, $100 for residents, fellows and students, and $50 for Penn Medicine faculty, staff, residents, fellows, and students.

All preregistered in-person attendees will receive access to the symposium, the program handout, continental breakfast, lunch, and breaks. Attendees will be required to sign-in to be marked as attended, receive credit and view the recorded content.

LIVE-STREAM (VIRTUAL) REGISTRATION:
The fees to attend virtually are as follows: $300 for physicians, $400 for Industry attendees, $175 for nurse practitioners, physician assistants and other healthcare professionals, $150 for residents, fellows and students, and $100 for Penn Medicine faculty, staff, residents, fellows, and students.

Attendees registered to attend virtually will receive an email that includes the link to join the symposium and the electronic program handout within 48 hours of the symposium. Virtual attendees will be required to sign onto the Live Stream broadcast using their first name, last name and email address to be marked as attended, receive credit and view the recorded content.

*Penn Medicine staff must register using a Penn Medicine email address to receive the discounted registration fee.

Need to Register by Mail?
Please note: mailed registrations may take more than 5-10 business days before they are received because we continue to experience longer delays in receiving mail. We encourage all attendees to register online. See the registration form for mailing instructions. All registrations will be confirmed by email as long as your registration is received before March 31, 2027.

BE SURE TO CHECK YOUR SPAM BOX FOR EMAILS REGARDING THIS CONFERENCE.

In support of improving patient care, Penn Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.  

Designation of Credit
Physicians: Penn Medicine designates this live activity for a maximum of 11.75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

ABIM MOC: Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 11.75 MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

Nurses: This program provides 11.75 NCPD Hours.

Physician Assistants: AAPA accepts certificates of participation for educational activities certified for AMA PRA Category 1 Credit™ from organizations accredited by ACCME or a recognized state medical society. PAs may receive a maximum of 11.75 Category 1 credits for completing this activity.

Pharmacists: This knowledge-based activity is approved for 11.75 ACPE contact hours of continuing pharmacy education credit.
UAN: 

Credits Per Day
Friday: 7.0
Saturday: 4.75
TOTAL: 11.75*
*Learners must attend both days to claim the maximum 11.75 credits

CANCELLATION POLICY 
In order to process refunds for course withdrawals, cancellations must be received in writing by March 19, 2027 (subject to a service charge equivalent to 10% of the registration fee, but no less than $25.00). No refunds will be issued thereafter.

The University reserves the right to cancel or postpone any course due to unforeseen circumstances. In the event of cancellation or postponement, the University will refund registration fees but is not responsible for related costs or expenses to participants, including cancellation fees assessed by hotels, airlines, and travel agencies.